Inspire Medical Systems (INSP)

• Market cap: $5.32B
• 1 day: 2.21%
• 5 days: -8.18%
• 1 month: -6.83%
• 3 months: -9.89%
• 6 months: 22.15%
• Year to date: -6.08%
• 1 year: -5.32%
• 5 years: 115.45%
• 10 years: 611.29%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,011

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

500% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 6 (+5) [Q3]

63% more capital invested

Capital invested by funds: $4.38B [Q2] → $7.13B (+$2.75B) [Q3]

44% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 55

6% more funds holding

Funds holding: 322 [Q2] → 342 (+20) [Q3]

3.26% more ownership

Funds ownership: 110.11% [Q2] → 113.36% (+3.26%) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 110

9% less call options, than puts

Call options by funds: $121M | Put options by funds: $132M

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $198 11% upside
• Avg. target: $238 34% upside
• High target: $260 46% upside

6 analyst ratings

• positive: 4 67%
• neutral: 2 33%
• negative: 0 0%

B of A Securities Bob Hopkins 50% 1-year accuracy 1 / 2 met price target	44% upside $255	Buy Upgraded	20 Nov 2024
RBC Capital Shagun Singh 46% 1-year accuracy 32 / 69 met price target	46% upside $260	Outperform Reiterated	5 Nov 2024
Piper Sandler Adam Maeder 63% 1-year accuracy 10 / 16 met price target	46% upside $260	Overweight Reiterated	5 Nov 2024
Stifel Jonathan Block 26% 1-year accuracy 5 / 19 met price target	13% upside $200	Hold Reiterated	5 Nov 2024
Wells Fargo Larry Biegelsen 63% 1-year accuracy 29 / 46 met price target	11% upside $198	Equal-Weight Maintained	5 Nov 2024